Primary pleomorphic adenoma of the trachea is rare, as only 33 cases have been previously report ed worldwide since 1922. We describe a new case of primary tracheal pleomorphic adenoma that wasdiscoveredincidentally in a78-year-old man. Thetumorwasexcised, and thepatient recoveredwithout complication. Salivarygland tumorsof thetracheashouldbeconsidered inthedifferential diagnosis of tracheal lesions; thediagnosis isconfirmedbypathologic evaluation. Patients are adequately treated with sleeve resection and primary anastomosis wheneverpossible.
Introduction
Mixed salivary gland tumors are uncommon, occurring in approximately 3 to 4 persons per 100,000 population worldwide.' Pleomorphic adenoma is the most common subtype, accounting for approximately half of the primary mixed tumors in the major salivary glands.' Pleomorphic adenomas have been documented in the tongue, retromolar trigone, lips, and trachea. ' The reported annual incid ence of primary tracheal tumors is 0.2 per 100,000 population worldwide.' Such tumors are responsible for less than 0.1% of all cancer deaths per year.' The most common primary tracheal tumors are squamous cell carcinoma and adenoid cystic carcinoma; among the others are a variety of salivary gland tumors, including pleomorphic adenoma and mucoepidermoid carcinoma.'
Since 1922,only 33 casesof primary tracheal pleomorphic adenoma have been previously reported worldwide in the otolaryngology and thoracic medicine literature. 3 In this article, we describe the 34th such case, and we review the histopathologic characteristics of th is rare tumor. 
Case report
A 78-year-old white man was referred to our otolaryngology clinic for evaluation of a tracheal mass. The mass had been discovered incidentally on computed tomography (CT) that had been obtained during a work-up for chronic neck pain. The patient denied any shortness of breath, hoarseness, or dysphagia. He had a significant medical and surgical history, including kidney stones, diet-controlled diabetes mellitus, bladder cancer diagnosed 10 years earlier and treated by total cystectomy, and cervical arthritic degenerative joint disease that required intermittent nerve block injections. His medications included ipratropium and albuterol inhalers for chronic obstructive pulmonary disease. His social history was significant for 47 pack-years of smoking, but he denied alcohol consumption. On physical examination, the patient was afebrile. He exhibited no tachypnea, signs of respiratory distress, or audible stridor. Findings on fiberoptic laryngoscopy were normal, including bilateral vocal fold mobility. Bronchoscopy revealed that a large (2-cm) polypoid lesion had originated on the anterior tracheal wall at the second tracheal ring. No cervical lymphadenopathy was found on palpation of the neck, and findings on the remainder of the head and neck examination were unremarkable.
New axial and sagittal CTs demonstrated a 2 x 1.2 x 2.2-cm anterior, intraluminal, heterogeneously enhancing tracheal mass at the levelofthe clavicle (figure 1). CT was also suggestive of central necrosis within the mass, but no significant lymphadenopathy or bony destruction of the clavicular heads was seen. CT of the thorax and whole-body positron-emission tomography were negative for metastatic lesions.
A tracheal resection with a primaryend -to-end anastomosis was performed. On microscopic examination,the tumor was found to be adjacent to the tracheal cartilage (figur e 2,A). Ductal structures were randomly scattered within a mesenchymal stromal component located between and around the epithelial elements. The ductal structures had large and distinct lumens as well as small, isolated, and poorly defined lumens. The lumens were lined with cuboidal and columnar epithelium with an ENT-Ear, Nose & Throat Joumal s May 2008 out er layer of spindle-type and clear cells. The stroma was mainly dens e and hyalinized, with focal areas of myxoid differenti ation ( figure 2, B) . The tumor was iden tified as a prim ary pleomorphic adenoma.
The patient underwent yearly follow-up imaging, and 4 years after surgical resection he remained asymptomatic.
Discussion
Grossly, pleomorphic adenomas are round or ovoid masses that are well demarcated and exhibit varying degreesofencapsulation. The intact surface isgray-white, and the cut surface is solid with partially translucent areasthatrepresentthe histologic variations .The tumors are composed of cells that demonstrate both epithelial and mesenchymal differentiation. The epithelial component con sists of ductal and nonductal cells that can be spindle-shaped, squamous, stellate, plasmacytoid, onco cytoid, cuboidal, or clear. The mesenchymal component consists of varying degrees of myxoid, hyaline, cartilaginous, and osseous differenti ation ; the proportion of each of these element s varies widely from case to case. Immunohistoch emically, th e ductal component may stain positive for keratin, epithelial membrane antigen, and carcinoembryoni c antigen. The spindlecell component is positive for keratin, smooth-muscle actin, and myosin . The cartilaginous areas are positive for 5-100 protein.
Fine-needle aspiration biopsy may be usefu l in identifying benign epithelial cells in a blue myxoid matrix back ground. However, given that the pathology of pleomorphic adenoma is characteristic for a number of morphologic features , a diagno sis based on fine-n eedle aspir ation biopsy and small incisional biop sies may be extr emely difficult to establish because of the tumor's widely diverse morphology and the characteristic heterogeneity between and within tumor types.
Pleomorphic adenoma of th e trachea, like adenoid cystic carcinoma and mu coepidermoid carcinoma, has a less aggressive clinical course th an does squamous cell carcinoma. The indolent course of the disease and its confusingpresentation posea diagnostic challenge. Most patient s have a history of slowly pro gressive dyspnea. Given th at most of these intratr acheal lesions are eith er subglottic or intrathoracic,expiratory or biphasicstridor may mimic non-neopla sticsyndromes,including asthma and bronchitis. In fact, Heifetz et al reported that 6 of 19 patients (31.6%) with pleomorphic adenoma of the trachea were initially misdiagnosed with asthma.' Other, Volume 87, Number 5 less common presenting signs and symptoms include hem optysis and chronic cough, but they may not manifest until th e lumen becom es at least 75% obstruct ed.' As a result, tracheal pleomorph ic adenoma is often not discovered until furth er diagnostic tests (i.e., imaging and bron choscopy with biopsy) are perform ed and th e intr aluminal trac heal mass is dete cted.
The literature lacks formal investigations on th e managem ent and lon g-term follow-up of patients with trachealpleom orphic adenom a.Witho ut evidence-based guidance, mo st surge ons treat pleomorphic adenomas of th e tr achea as th ey treat tumors of th e major salivar y glands. Th e prim ary therapeutic modality is complete excision of the tumor via tr acheal resection. With regard to sur gery on major salivary glands, we know that keeping the capsule intact and resecting a margin of normal tissue reduces the lO-year recurrence rate to app roximatel y 2%. 6 To the best of our knowledge, no case of recur rent tracheal pleomorphic adenoma has been reported following complete excision.
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290· www.entjournal.com Asis the casewith the treatment of tumors of the major salivary glands, altern ative but less effective treatment modalities are available for primary tracheal pleomorphic adenomas in the event that surgery fails. Neutron radiotherapy, which is known to be superior to conventional radiotherapy in treating salivary gland tumors, is reserved for patients with residual disease after surgical resection and for patient s with recurrent pleomorphic adenoma.' Chemotherapy, which is used for palliative pain control in carcinoma of the salivary glands, has no th erap eutic role in pleomorphic adenoma."
